Our first experience with combined positron emission tomography and computed tomography (PET/CT) in patients with gastric cancer
Journal Title: Współczesna Onkologia - Year 2005, Vol 9, Issue 5
Abstract
The application of positron emission tomography (PET) using F-18-fluorodeoxyglucose (FDG) is the latest method of functional imaging of the human body, trunk, or selected human organs. In oncology diagnostics, it uses the enlarged uptake of positron radiotracer, by cancer cells. FDP-PET scanning and computed tomography (CT) offer wider diagnostic possibilities. FDG-PET and PET/CT are used more and more frequently in patients having gastrointestinal malignancies, especially colorectal, esophageal and pancreas carcinoma. This paper is a retrospective assessment of PET/CT fusion images in 22 patients with gastric cancer. The reason for this diagnosis in 12 out of 22 patients was suspicion of recurrent gastric cancer after surgery, in 5 cases - cancer progression assessment before surgery, in 4 – assessment after the end of treatment, in one of them - assessment of chemotherapy efficacy. Focal increased FDG uptake was found in 9 patients. In 7 patients recurrent gastric cancer after treatment was observed and in one patient - primary gastric cancer. Correctness of PET/CT scan was assessed on the basis of clinical remarks of patients, additional examination (chest roentgenogram, abdomen cavity ultrasonography and CT, histopathological examination) and intraoperative examination. In 9 patients PET/CT was true positive, in 3 patients - false negative, and in all the other – true negative. A correlation between scan results and a histopathological structure was noticed. PET/CT image in selected patients with gastric cancer provides a useful diagnostic method of primary staging and detection of a recurrent disease, restaging and treatment monitoring. First primary experiences justify the assessment of PET/CT findings in patients with gastric cancer for a prospective study.
Authors and Affiliations
Zbigniew Kula, Jarosław Szefer, Tomasz Pietrzak, Zdzisław Zuchora
Keywords
Related Articles
- EP ID EP82292
- DOI -
- Views 82
- Downloads 0
HDR brachytherapy of skin cancer - the Wielkopolski Cancer Centre\'s experience
Purpose: To analyze treatment results of HDR brachytherapy (BT) in patients with skin tumors. Material and methods: 179 patients with skin tumor were treated with HDR BT in the Wielkopolski Cancer Center between May 199...
The activity of N-acetyl-β-glucosaminidase and its isoenzymes in the renal tissue, serum and urine of patients with renal cancer
Renal cancer makes up around 3-4% of human neoplasms. It may metastasise, infiltrate and colonise other tissues. Infiltration and metastasis may depend on changes in the oligosaccharide structures of glycoconjugates of t...
Cytokiny jako niezależne czynniki prognostyczne u chorych na nowotwory złośliwe
W prowadzonych badaniach wykazano, że stężenia wielu cytokin i ich wolnych receptorów są podwyższone u dużego odsetka chorych na raka jajnika, jelita grubego, niedrobnokomórkowego raka płuca oraz mięsaki tkanek miękkic...
How 5-fluorouracil acts
5-fluorouracil (5-FU) has proved to be one of the most effective chemotherapeutics for colorectal cancer. It is also used as a drug against breast, head and neck, esophageal, gastric, and several other cancers. Intracell...
Squamous cell carcinoma antigen (SCC) in diagnostics and monitoring treatment of patients with cervical cancer
Squamous cell carcinoma antigen (SCC) is the first marker of squamous cell carcinoma and a member of the serin proteinase inhibitor family. Increased concentration of SCC occurs in squamous cancers of the region of the h...